Literature DB >> 23630959

Phylogeographic origin of Helicobacter pylori determines host-adaptive responses upon coculture with gastric epithelial cells.

Alexander Sheh1, Rupesh Chaturvedi, D Scott Merrell, Pelayo Correa, Keith T Wilson, James G Fox.   

Abstract

While Helicobacter pylori infects over 50% of the world's population, the mechanisms involved in the development of gastric disease are not fully understood. Bacterial, host, and environmental factors play a role in disease outcome. To investigate the role of bacterial factors in H. pylori pathogenesis, global gene expression of six H. pylori isolates was analyzed during coculture with gastric epithelial cells. Clustering analysis of six Colombian clinical isolates from a region with low gastric cancer risk and a region with high gastric cancer risk segregated strains based on their phylogeographic origin. One hundred forty-six genes had increased expression in European strains, while 350 genes had increased expression in African strains. Differential expression was observed in genes associated with motility, pathogenicity, and other adaptations to the host environment. European strains had greater expression of the virulence factors cagA, vacA, and babB and were associated with increased gastric histologic lesions in patients. In AGS cells, European strains promoted significantly higher interleukin-8 (IL-8) expression than did African strains. African strains significantly induced apoptosis, whereas only one European strain significantly induced apoptosis. Our data suggest that gene expression profiles of clinical isolates can discriminate strains by phylogeographic origin and that these profiles are associated with changes in expression of the proinflammatory and protumorigenic cytokine IL-8 and levels of apoptosis in host epithelial cells. These findings support the hypothesis that bacterial factors determined by the phylogeographic origin of H. pylori strains may promote increased gastric disease.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23630959      PMCID: PMC3697613          DOI: 10.1128/IAI.01182-12

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  66 in total

1.  Chemokine growth-regulated oncogene 1 as a putative biomarker for gastric cancer progression.

Authors:  Jae-Joon Jung; Sewon Noh; Hei-Cheul Jeung; Minkyu Jung; Tae Soo Kim; Sung Hoon Noh; Jae Kyung Roh; Hyun Cheol Chung; Sun Young Rha
Journal:  Cancer Sci       Date:  2010-08-22       Impact factor: 6.716

2.  Gene expression profiling of Helicobacter pylori reveals a growth-phase-dependent switch in virulence gene expression.

Authors:  Lucinda J Thompson; D Scott Merrell; Brett A Neilan; Hazel Mitchell; Adrian Lee; Stanley Falkow
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

3.  Mutation of luxS affects motility and infectivity of Helicobacter pylori in gastric mucosa of a Mongolian gerbil model.

Authors:  Takako Osaki; Tomoko Hanawa; Taki Manzoku; Minoru Fukuda; Hayato Kawakami; Hidekazu Suzuki; Hiroyuki Yamaguchi; Xu Yan; Haruhiko Taguchi; Satoshi Kurata; Shigeru Kamiya
Journal:  J Med Microbiol       Date:  2006-11       Impact factor: 2.472

4.  Virulence-associated genotypes of Helicobacter pylori: do they explain the African enigma?

Authors:  Luis E Bravo; Leen-Jan van Doom; J Luis Realpe; Pelayo Correa
Journal:  Am J Gastroenterol       Date:  2002-11       Impact factor: 10.864

5.  Gene expression in vivo shows that Helicobacter pylori colonizes an acidic niche on the gastric surface.

Authors:  David R Scott; Elizabeth A Marcus; Yi Wen; Jane Oh; George Sachs
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-16       Impact factor: 11.205

6.  comH, a novel gene essential for natural transformation of Helicobacter pylori.

Authors:  L C Smeets; J J Bijlsma; S Y Boomkens; C M Vandenbroucke-Grauls; J G Kusters
Journal:  J Bacteriol       Date:  2000-07       Impact factor: 3.490

7.  Helicobacter pylori activate epidermal growth factor receptor- and phosphatidylinositol 3-OH kinase-dependent Akt and glycogen synthase kinase 3beta phosphorylation.

Authors:  Fazal H Tabassam; David Y Graham; Yoshio Yamaoka
Journal:  Cell Microbiol       Date:  2008-09-08       Impact factor: 3.715

8.  Gene expression analysis identifies over-expression of CXCL1, SPARC, SPP1, and SULF1 in gastric cancer.

Authors:  Siina Junnila; Arto Kokkola; Toru Mizuguchi; Koichi Hirata; Marja-Liisa Karjalainen-Lindsberg; Pauli Puolakkainen; Outi Monni
Journal:  Genes Chromosomes Cancer       Date:  2010-01       Impact factor: 5.006

9.  Helicobacter pylori--a seasoned pathogen by any other name.

Authors:  Niyaz Ahmed; Shivendra Tenguria; Nishant Nandanwar
Journal:  Gut Pathog       Date:  2009-12-23       Impact factor: 4.181

10.  An African origin for the intimate association between humans and Helicobacter pylori.

Authors:  Bodo Linz; François Balloux; Yoshan Moodley; Andrea Manica; Hua Liu; Philippe Roumagnac; Daniel Falush; Christiana Stamer; Franck Prugnolle; Schalk W van der Merwe; Yoshio Yamaoka; David Y Graham; Emilio Perez-Trallero; Torkel Wadstrom; Sebastian Suerbaum; Mark Achtman
Journal:  Nature       Date:  2007-02-07       Impact factor: 49.962

View more
  13 in total

1.  Epidermal growth factor receptor inhibition downregulates Helicobacter pylori-induced epithelial inflammatory responses, DNA damage and gastric carcinogenesis.

Authors:  Johanna C Sierra; Mohammad Asim; Thomas G Verriere; M Blanca Piazuelo; Giovanni Suarez; Judith Romero-Gallo; Alberto G Delgado; Lydia E Wroblewski; Daniel P Barry; Richard M Peek; Alain P Gobert; Keith T Wilson
Journal:  Gut       Date:  2017-05-04       Impact factor: 23.059

Review 2.  Human and Helicobacter pylori Interactions Determine the Outcome of Gastric Diseases.

Authors:  Alain P Gobert; Keith T Wilson
Journal:  Curr Top Microbiol Immunol       Date:  2017       Impact factor: 4.291

3.  Novel Helicobacter species H.japonicum isolated from laboratory mice from Japan induces typhlocolitis and lower bowel carcinoma in C57BL/129 IL10-/- mice.

Authors:  Zeli Shen; Yan Feng; Sureshkumar Muthupalani; Alexander Sheh; Lenzie E Cheaney; Christian A Kaufman; Guanyu Gong; Bruce J Paster; James G Fox
Journal:  Carcinogenesis       Date:  2016-09-21       Impact factor: 4.944

4.  Increased Helicobacter pylori-associated gastric cancer risk in the Andean region of Colombia is mediated by spermine oxidase.

Authors:  R Chaturvedi; T de Sablet; M Asim; M B Piazuelo; D P Barry; T G Verriere; J C Sierra; D M Hardbower; A G Delgado; B G Schneider; D A Israel; J Romero-Gallo; T A Nagy; D R Morgan; T Murray-Stewart; L E Bravo; R M Peek; J G Fox; P M Woster; R A Casero; P Correa; K T Wilson
Journal:  Oncogene       Date:  2014-09-01       Impact factor: 9.867

Review 5.  Friend and foe: factors influencing the movement of the bacterium Helicobacter pylori along the parasitism-mutualism continuum.

Authors:  Derek Lin; Britt Koskella
Journal:  Evol Appl       Date:  2014-11-20       Impact factor: 5.183

Review 6.  Helicobacter pylori: Genomic Insight into the Host-Pathogen Interaction.

Authors:  Kathryn P Haley; Jennifer A Gaddy
Journal:  Int J Genomics       Date:  2015-02-05       Impact factor: 2.326

7.  Draft Genome Sequences of Helicobacter pylori Strains Isolated from Regions of Low and High Gastric Cancer Risk in Colombia.

Authors:  Alexander Sheh; M Blanca Piazuelo; Keith T Wilson; Pelayo Correa; James G Fox
Journal:  Genome Announc       Date:  2013-09-19

8.  Draft genome sequences of eight enterohepatic helicobacter species isolated from both laboratory and wild rodents.

Authors:  Alexander Sheh; Zeli Shen; James G Fox
Journal:  Genome Announc       Date:  2014-11-26

9.  Interleukin-8 does not influence proliferation of the SGC7901 gastric cancer cell line.

Authors:  Jun Shi; Pin-Kang Wei
Journal:  Oncol Lett       Date:  2014-09-12       Impact factor: 2.967

Review 10.  Helicobacter pylori-related risk predictors of gastric cancer: The latest models, challenges, and future prospects.

Authors:  Seyedeh Zahra Bakhti; Saeid Latifi-Navid; Reza Safaralizadeh
Journal:  Cancer Med       Date:  2020-05-04       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.